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Scaffolds are instrumental in the engineering of functional tissues, and therefore have been an 
intense area of interests within the regenerative biology and medicine areas of research and 
development. Many approaches exist for creating scaffolds with either natural or synthetic 
advanced materials, which are subsequently coupled with cells and other materials, and 
microintegrated with the aid of a bioreactor, finally forming a functional three-dimensional 
tissue. Although many advances have been made over the years, none of these have truly been 
successful as postulated by literature for either biomedical or clinical utility. For e.g. 
generated reconstructs, have many limitations, such as poor cell infiltration throughout the 
entire depth of the scaffold, to the associated cost and time for generating functional 
reconstructs mimicking native tissue. These and other roadblocks have truly limited the use of 
scaffolds as tissue engineering biomaterials/building blocks in regenerative medicine. 
However, these previously faced obstacles have recently been overcome with new scaffolding 
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technologies unearthed and pioneered in 2005, which demonstrate the ability to directly 
handle large quantities of multiple cell types with both a biopolymer and other advanced 
materials for simultaneously forming a three-dimensional living reconstruct mimicking native 
tissues. These recently discovered platform biotechnologies will truly have significant 
ramifications to the engineering of a three-dimensional tissue and for regenerative medicine in 
general as these platforms are versatile.  
 
1. Introduction 
As clinical medicine advances, rapidly with substantial achievements, the estimated lifespan 
of humans have significantly increased. Although these advancements are noteworthy they 
bring with them associated obstacles faced as our bodies age, thus having to tackle new 
challenges such as aging/dysfunctional tissues and organs. Addressing tissue and organ 
transplantation has been successful to some degree but has associated issues such as the 
limited availability in tissues and organs from donor pools to the recipient, to post-
transplantation requiring lifelong immunosuppression, giving rise to a wide range of 
significant side effects. Therefore, tissue and organ shortage could be met by the 
reconstruction and development of synthetic tissues where a natural or synthetically 
developed scaffold is fully cellularised with the patient’s own cells. Thus, eliminating the 
need for donor tissues/organs and the need for life long immunosuppression. Consequently, 
we find ourselves today at this stage of the challenge seeking new methods, tools and 
materials for generating synthetic tissues for addressing our wellbeing. The author also notes 
that reconstructing a whole organ such a dense (heart or liver etc) or hollow (trachea) one is a 
challenge of unimaginable magnitude/complexity and therefore the author focusses on tissue 
reconstruction and development for the patching of aging/damaged organs, which in itself is a 
task of mammoth proportion. An interesting thought is that organ replacement being complex 
does not end with the associated biological and medical issues but also has the association of 
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whether the transplanted organ is conditioned for the recipient’s anatomical structure and 
dimensions – which is also an aspect requiring careful consideration prior to any 
transplantation.  Therefore, this endeavor has seen the coming of cross fertile collaborations 
for coupling the life sciences with the physical sciences. Molecular, cellular and 
developmental biologists have achieved great advancements where they have increased our 
know-how into these respective fields, with the particular achievement of the discovery of 
induced pluripotent stem (iPs) cells, [1] which provides many opportunities for cellular based 
therapies to the reconstruction and development of tissues and organs. Similarly, physical 
scientists have over many years developed novel direct cell assessing and handling 
approaches which have seen the development of platform technologies such as flow 
cytometry. That being said there is much misinterpretation about scaffolds in regenerative 
biology and medicine. Hence it is only recently that in the endeavor of developing synthetic 
tissues, some scientists have come to realise that scaffolds take precedence, as they provide 
the much-needed support that cells require to carry out their function in three-dimensions, 
from migration, adhesion to communication with its surrounding cells to a whole host of other 
functions as they do in native tissues and organs. It is well-established that tissues containing 
limited or lacking such supports have significant effects on their ability to undergo repair, 
regeneration to rejuvenation. In fact, from a molecular level upwards cells have been shown 
to change in both phenotype and genotype as a result of lacking a supporting scaffold. [2]    
 
Tissue engineers classically have been chasing the idea that cells coupled with a scaffold 
would allow the reconstruction of a living tissue. This notion however is an incomplete one as 
merely coupling cells with a scaffold falls short of creating a true three-dimensional fully 
microintegrated scaffold. Many such studies elucidating the development of scaffolds 
alongside their ability to harbor cells with existing and new biomaterials, have shown some 
interesting advancements. Although these achievements have been commendable, their 
  
4 
 
adoption into the biomedical sciences and clinical medicine has been seldom due to their 
inability to have uniform and complete cellularisation throughout the scaffold thickness, to 
their costs and time for their generation. Therefore, in this critical review the author wishes to 
highlight clearly the advantages and disadvantages of those scaffolding technologies bearing 
in mind the end goal, which is to see their utility in either the biomedical and/or clinical arena. 
The readers are strongly reminded that, the technologies discussed in this review have been 
carefully chosen based on their promise to possibly generate a fully functional soft and dense 
reconstruct cost effectively, requiring a minimum number of processing steps, together with 
the shortest time for recreating a living tissue/organ which mimics a native tissue/organ.      
 
 
2. Methods of generating scaffolds for engineering functional soft & dense reconstructs 
The author simplifies these methods into two categories, namely, in-direct and direct 
approaches. The in-direct methods referred to here are those approaches that cannot handle 
the cells with other materials, namely the biopolymer with the addition of other biomolecules 
etc for directly forming a living structure. Hence these methods have many steps and are time 
consuming for reaching its end goal. The reader must note at this stage that there are some 
approaches that are referred to as either scaffold-less or scaffold-free technologies, for tissue 
engineering. These are at best misleading terms or concepts, as scaffolds are a prerequisite for 
developing a functional tissue of any kind. [2]   
 
2.1. In-direct methods of scaffolding 
These methods of scaffolding, are those approaches having many individual steps for 
developing the scaffold, subsequently manually seeded with cells, which undergoes many re-
seeding steps with increased and cyclic bioreactor times in the hope to encouraging 
microintegration of the cells and scaffold. There are many methods apart from those 
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highlighted in this section which have also generated scaffolds by way of in-direct methods, 
however the author chooses not to highlight them, as they require a large number of 
processing steps thus implying long periods of time or their inability to reconstruct a three-
dimensional fully cellularised architecture both cost effectively and in three-dimensions 
relevant for human transplantation. The reader should note well that in these in-direct 
methods architectural changes requires a mold or transfer architecture to be altered/modified 
and thus implies additional costs with the requirement for changing the deemed final 
cellularised architecture.   
 
2.1.1 Lithography technologies 
Lithography technologies [3] (see figure 1 for illustration on soft-lithography) have many 
manifestations but essentially they either explore pre-organized architectures in the form a 
stamp to transfer molecules from the stamp as a pattern onto a pre-fabricated surface or the 
writing (dip-pen lithography) which transfers molecules with the aid of a fine edged cantilever, 
subsequently encouraging cells to adhere and grown on the transferred molecular architecture. 
The approach is unique in that its ability to call cells to seed onto pre-formed architectures 
which the cells take shape of and proliferate. However, the re-transfer or stacking of 
molecules onto the cellular surface created through the previous step for forming the second 
cellular layer, unfortunately is unachievable as the transferring process has been found to 
damage and destroy a majority of cells previously adhered. Additionally, the process requires 
multiple steps and therefore it is both time consuming and laborious while also demanding the 
maintenance of sterility over the entire process. That being said the technology could be 
useful for assessing adherent cells individually in conjunction with a laser to understanding 
basic biology, where cell(s) could be introduced to compounds (in the nano scale <50nm) and 
analyzed via time-lapse microscopy for assessing a wide range of cellular function in two-
dimensions. [4]  
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Figure 1. Illustrates the typical stages of exploring soft-lithography A) transferring (by 
stamping) the molecules in a pre-organized architecture and orientation, B) the introduction of 
a cell suspension to the transferred molecular architecture and incubation and finally C) the 
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cells within the suspension migrating and adhering to the transferred molecular architecture. 
This basic concept is by far followed by a majority of lithography approaches.   
 
Both soft- and dip-pen lithography have undergone some modifications/manifestations where 
in the case of soft-lithography the stamping approach was used for creating small cell friendly 
semi-solid blocks made of biocompatible materials, which when introduced and incubated 
with a cell suspension encouraged cell infiltration into these biopolymer blocks. [5] This 
however once again is time dependent as cells are required to migrate in their own time, 
additionally to develop a tissue of practical utility would be near impossible. Similarly, the 
advancement in dip-pen lithography which writes out the architecture with molecules while 
the fine cantilever periodically replenishes its molecules at the tip of the pen by moving back 
and forth from a reservoir holding the molecules has now a continuous feeding tip. [6] This 
could see cells being deposited onto a substrate, which would be pre-fabricated, the author 
sees the impracticality, where cellular clogging may take place when cells and a viscous 
biopolymer is processed within this continuous feed system. Although these lithography 
technologies are inefficient for cell driven aspect within the biomedical based applications, 
the technologies have implications to niche areas of research which require accurate protein to 
DNA and other biomolecular placement for diagnostic and analytical applications. [7] Other 
lithography family technologies such as stereolithography and photolithography [8] have also 
undergone exploration for forming cellularised architectures, but these have many limitations 
such as the inability to have controlled densities of cells compartmentalized in a given 
permutation and combination with and without the addition of other materials. To finally the 
processes (lasers generate significant amounts of heat etc) having negative effects on cells 
during the stage where cells are entrapped by solidifying/crosslinking and compartmentalizing.   
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2.1.2. Chemical methods  
Chemical approaches for developing scaffolds have been by way of exploiting rapidly 
evaporating solvents with FDA approved biopolymers. Here the biopolymer (which largely is 
provided as a powder/flakes) is solubilized in a fast evaporating solvent and then cast into the 
required shape using a mold of some kind, and allowed to either dry in a desiccator or with 
the addition of reactive chemicals to the application of heat/UV etc. These approaches have 
been demonstrated to form scaffolds rapidly. [9] However, the process has no control over the 
generated pore sizes nor control over the pore frame sizes or their uniformity throughout the 
scaffold (see figure 2).  
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Figure 2. Chemical-based scaffolding approach showing A) biopolymer and/or suspension 
being placed in the mold, B) the introduction of the cross-linking mechanisms (heat, light or 
chemical etc) to finally C) the generated biopsy punched scaffold having dimples and voids. 
Cells could be mixed in with some cell friendly polymer and cast with the aid of a mold. 
However, cell distribution over the molded architecture would be varied and random as cells 
would settle down during the crosslinking process.  
 
Scaffolds generated by this approach has been introduced to cells by way of manual seeding 
and found to encourage cell growth within them. [10] Cells are found to grown in and out of 
the pores but long term cellular growth has not been reported widely nor has any in-depth in-
vivo studies been carried out. A few reasons for this are those fast evaporating 
solvents/reacting chemicals could leave residual traces which have been found to have 
triggered cellular death or inflammation in those in-vivo investigations. Addressing this is an 
issue as residual compounds from those chemicals explored are extremely difficult to fully 
remove from the generated scaffolds. An interesting aspect the author has come to realize 
from such scaffolds and others like these, have been that some scientists regard the adhered 
cells on the inner and outer surfaces in these pores whilst proliferating and stacking 
themselves on each other, is a tissue in three-dimensions. The author disagrees with this 
notion that these cells are in three-dimensions. In fact, they are in two-dimensions at best as 
their plane of adherence is in two-dimensions. Additionally, nutrients much required by cells 
for maintaining their dynamic metabolisms have limited access to such molecules as they 
have to pass across barriers/membranes which are part of the scaffold or tightly packed 
cellular layers. These views are even more so when cells are adhered on pore frames or struts 
which are larger than the diameter of the cells itself.  These limitations have been investigated 
and have been found to have detrimental effects in-vivo as the cell-adhered architectures have 
given rise to what is known as foreign body reactions. [11] Hence for these and other reasons 
  
10 
 
such constructs have been limited in their exploration. Manifestations of this approach have 
been where friendly biopolymers such as alginate (including those doped with collagen etc) 
has been mixed with cells and either drawn into fibers using immersed needles in calcium 
chloride (to other cross-linking solutions), or threads into this cell bearing polymer, which 
have been found to generate cell-bearing fibers. [12] That being said, such constructs have 
limited utility in building a three-dimensional architecture without further processing, as the 
cell bearing constructs are generated as single strands. [13] 
 
2.1.3. 3D printing  
This is technology that adds materials when required and thus unlike the previous 
technologies, significantly reduces material waste during the architectural forming step. [14] 
An interesting manufacturing concept which brings to the table the ability to eliminate the 
need for molds. 3D printing could be carried out in many methods, meaning there are many 
approaches to dispensing or extruding materials for forming a three-dimensional architecture. 
These would primarily range from ink-jet printing (solenoid, piezoelectric, thermal), to 
extrusion approaches ranging from thermal sleeve heated systems to those which are 
screw/plunger driven (see figure 3). [15] These approaches in their many manifestations have 
been shown to generate some complex architectures which are truly magnificent. This 
printing approach is essentially a 2D materials deposition approach which is used for layering 
multiple times (or stacking) for creating the third dimension (z-axis). However, these 
architectures are generated with classical materials, and thus are an ideal approach for 
creating architectures for the rapid prototyping industry. The 3D printing community has 
tirelessly struggled however to extend this approach for the last 20 years or so, for directly 
handling cells (with and without other materials) with a biopolymer for creating a self-
standing fully cellularised architecture, requiring no additional assistance during the formation 
stage. These efforts have been unsuccessful as they are hindered by the extrusion methods 
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themselves, which stem from these materials handling approaches having direct application of 
their driving forces applied on the cells while exploring fine bore needles, and thus have seen 
to cause many cellular damage, clogging of needles to a wide range of other issues which 
have harm on the cells themselves. [16] Additionally, these explored fine bore needles used in 
order to form architectures at small scales (in the micrometer) have other ramifications to the 
manufacturing process. This is a challenge for these processes as the technologies undergo 
needle wetting effects to those referred to as the barus effect [17] which have negative 
implications or the generated sizes of either droplets or filaments. Hence the formed 
droplets/threads which are roughly double the diameter of the needle used, thus on deposition 
of the material, further spreading occurs on the substrate making manufacturing in the few 
tens of micrometers a tremendous challenge. [18]       
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Figure 3. Three-dimensional printing illustrating the three-major materials extrusion 
methodologies. 
 
A recent addition to the 3D printing portfolio is melt electrospinning writing. [19] This 
technology works on extruding a polymer melt across two charged electrodes between which 
a substrate is placed. One electrode holds the melt flowing through it, which is also charged to 
a high voltage with respect to either a grounded electrode which has in contact or above it a 
substrate for collecting the extruding polymer melt. The process conceptually is similar to the 
other 3D extruders with the exception that this process explores an electric field to draw out a 
polymer filament. One notable advancement this approach overcomes faced by those other 3D 
printing approaches is that this technology namely, electrospinning explores large bore 
needles from which fine polymer filaments are drawn out thus avoiding all issues limited by 
other approaches to the most important which is the ability to form fine polymer filaments 
extending even to the nano-regime. [20] That being said, the technology much like its other 3D 
printing cousins cannot handle living cells as the melt temperature could compromise cellular 
viability. It is important for the reader to note at this stage the technology referred to as 
continuous liquid interface production (CLIP), which is a renamed and a retrofitted 
technology, combines chemical methods and three-dimensional printing. CLIP is not a new 
technology but combines approaches to build 3D architectures layer by layer within a liquid 
environment, much like other direct write technologies. [21] Hence CLIP and these other direct 
write technologies can build architectures with classical materials, however this is not the case 
with living cells as the processes have not yet seen the development of bio-friendly media, 
where such structures could be developed with cells, or if such media are available 
maintaining cellular distribution within the developed architecture would be near impossible 
as the cells would sediment to the based during the structural formation stage. This would 
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result with the cellular architecture taking a 2D form as opposed to 3D. Additionally these 
procedures may have negative effects on the direct handling of dense cell populations. [3-21]       
 
2.1.4. Cell sheeting 
This technology yields from the advancement of surface technology. [22] The approach works 
on the principal of having cell culture dishes coated with a specialized polymer, which allows 
cells to be seeded (figure 4), proliferate and reach confluence. Once the given cell type 
reaches confluency the cell culture dish is brought to a lower temperature wrt incubation 
temperature, at which stage the cells together with their generated extra cellular matrix peels 
off as a sheet. The process has been clinically utilized successfully for forming monolayered 
single cellular sheets for repairing human cornea. [23] Although the author feels this is a neat 
accomplishment, engineering a dense fully functional multi cellular architecture has yet to be 
generated for either laboratory or clinical utility. Although not reported, we have found that 
the technology is laborious for creating a multicellular construct, which could sustain living 
over a function of time. This results from poor vascularization of the generated 3D construct, 
by way of stacking multiple cell type sheets, which inhibit vascularization to take form in the 
z-axes through the staked multiple cellular sheets. Never the less the technology could have 
potential for the fabrication of singular or multiple cellular type sheets for applications such as 
skin repair/wound healing.       
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Figure 4. Cell sheeting A) the deposition of a cell suspension on the coated culture dish, B) 
the filled culture dish containing the cell suspension which would be left till cells are 
confluent in an incubator to finally C) the peeling off the cellular sheet containing the cells 
with their generated extracellular matrix at a lower temperature. 
 
2.1.5. Force Spinning 
In the past two decades fibers, have taken precedence due to their practical applicability in the 
real world. Force spinning is a technology reminiscent of the candy floss machine (figure 5) 
which exploits centrifugal forces [24] to extrude fibers from either a fast evaporating polymer 
suspension or a melt. The technology has some advantage that it does not require any special 
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the filled culture dish containing the cell suspension which would be left till cells are 
confluent in an incubator to finally C) the peeling off the cellular sheet containing the cells 
with their generated extracellular matrix at a lower temperature. 
 
2.1.5. Force Spinning 
In the past two decades fibers, have taken precedence due to their practical applicability in the 
real world. Force spinning is a technology reminiscent of the candy floss machine (figure 5) 
which exploits centrifugal forces [24] to extrude fibers from either a fast evaporating polymer 
suspension or a melt. The technology has some advantage that it does not require any special 
equipment or instrumentation, but is hindered by the fact that it cannot generate fibers which 
A) B) 
C) 
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equipment or instrumentation, but is hindered by the fact that it cannot generate fibers which 
could be cross stitched, and requires a drum or removable cylinder like substrate which wraps 
around as a drum for fiber/scaffold collection. There are many manifestations of this 
technology retrofitted and renamed but the limitations are yet to be overcome. Interestingly 
one such manifestation which should provoke readers are where this technology was coupled 
with electric fields for directing the fibers onto a conveyer belt for making large quantities of 
scaffold sheets etc. [25] The provoking part here is that these investigators have combined two 
technologies namely force spinning and electrospinning to do what electrospinning can do 
alone, without requiring the rotational element thus introducing a waste in energy! There are a 
few scientists exploring this technology for small scale lab-based scaffold generation but it is 
hard for the author to see the practicality of this process entering larger scale production 
through its rotational fiber/scaffold formation approach. A few research groups have tried to 
incorporate cells into the spinning polymer but have found the polymer to loses a significant 
proportion of its liquid thus dehydrating the entrapped cells which significantly reduces their 
viability, to losing cell entrapment during the rapid fiber spinning process.       
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Figure 5. The equipment set-up used for force spinning fibers for generating scaffolds and 
membranes. 
 
2.1.6. Electrosprays and electrospinning 
Electrospraying and electrospinning (figure 6) have been around for at least a century. [26] 
These approaches work on the principal of charging a liquid within a conducting needle, 
which is placed in an electric field with respect to a grounded or oppositely charged electrode. 
The potential difference between the electrodes, in stable conditions have been shown to form 
a liquid cone at the needle exit with a jet emanating from its apex, which either subsequently 
breaks down into a three-dimensional conical spray plume (electrosprays – generates droplets) 
or a continuously elongating thread from the jet (electrospinning – generates fibers thus 
forming scaffolds and membranes). Both these techniques operate at very high voltage, 
typically in the 1000’s of volts. Interestingly these approaches have been shown to generate 
droplets and fibers in the few nanometers having a wide range of features unrivaled by all 
other technologies. [27] These features could range from hollow, porous to a wide range of 
both surface and bulk features having multiple purpose for a given end application. [28] These 
multi-featured droplets and fibers are generated by way of either coaxial [29] or tri-needle [30] 
systems to those which are coupled with a wide variety of counter electrodes. [31] The reader 
should appreciate that, these techniques unlike their rivals explore needles in the several 
hundreds of micrometers but are able to generate either droplets or fibers in the few 
nanometers. Hence these features propel these technologies ahead of its competitors for these 
and many more reasons which will be discussed in detail in this review. A whole host of 
advanced materials have been processed using these two approaches and found to generate a 
wide range of architectures having utility for many applications. [32] The reader should also 
note that these techniques (both electrospraying and electrospinning) have also been 
developed to print three-dimensional architectures layer by layer. [33] Most notably 
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electrospinning based three-dimensional printing has a significant disadvantage, where 
stacked layers cause interference with the electric field with increasing number of layers and 
results in random deposition. [34] This limitation has been overcome to some extent by the 
modification of the collection method or substrate. [33] Although this might be a solution it 
comes with a cost as these substrates are not economical to modify when required. This 
interference driven limitation has recently been removed by the introduction of electric field 
focusing plates and rings which have eliminated this obstacle. [35] Captivatingly its sister 
technology, electrosprays have undergone development to see the unearthing of a true three-
dimensional printing technology which required no molds of any kind to act as supports 
during the forming stage to the most important feature, namely when printing overhangs etc 
unlike rival technologies. [36] In the biomedical and clinical arena, architectures generated by 
means of electrospinning has limitations where the generated hollow and/or porous (or other 
featured) architectures have been found to limit their utility. For e.g. scaffolds generated by 
way of electrospinning have been found to inhibit cell infiltration throughout the entire 
thickness of the scaffold, therefore these scaffolds are now being investigated and 
commercialized for contraception. [37] Proving that the smallest human self-propelling cell 
(sperm cells) is unable to infiltrate through the fine voids found in generated scaffolds via 
electrospinning. Moreover, these techniques can directly handle living cells without damaging 
them form a molecular level upwards!   
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Figure 6. Illustrations of A) electrospraying and B) electrospinning.    
 
2.1.7. Decellularization and recellularisation 
This process explores the concept of retaining the backbone structure of a tissue/organ by 
removing its cellular contents thus leaving behind a near-intact collagen structure. [38] The 
concept strives to completely remove cells from a tissue or organ thus removing the 
individual’s signature, namely DNA etc. In the process the tissue or organ is sourced either 
from the donor pool or from an animal source. The procedure (figure 7) in brief involves 
using a biocompatible chemical cocktail to tease out the cells within the tissue or organ of 
choice thus leaving behind the collagen structure of the tissue/organ. Following cell removal, 
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the tissue is reintroduced to a new cell source namely the recipients, thus these adult cells are 
cued to home to their given location within a tissue or organ allowing the reconstruction of 
the tissue or organ with a new cell source. The process has worked in animals and some 
human trials have been successful. [39] However, although this is an interesting concept the 
author feels this approach takes one step forward and three steps back! It is hard to envisage 
this approach ever entering clinical utility for everyone as it demands all of its tissues and 
organs from the already oversubscribed donor pool or from an animal source both which 
demand lifelong immunosuppression, which brings with it many complications. The 
complications evolve as DNA removal is not complete and the remaining structure is known 
to lose its integrity due to the cell removal process. [40] This approach could have some 
application, for example in the generation of a thin non-life threatening tissue. [41] 
 
 
 
Figure 7. Demonstrates the A) dysfunctional kidney, B) striped of its cells completely, only 
leave its scaffold backbone. Subsequently panel C) shows cells from the recipient are 
introduced to the scaffold and these adult cells home to their respective locations in the organ. 
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Although in-direct methods could be argued as having some laboratory applications their 
ability to translate from the biomedical laboratory to the clinic is yet to be seen and realised 
practically. These issues arise from their inability to generate practical size tissues most 
relevant to humans alongside their associated processing times/number of steps to the 
involved costs for reconstructing a tissue/organ which could be transplanted. 
 
The author would like to make aware to the readers at this point that there are other methods 
currently being investigated for developing tissues/organs, within living animals. These 
methods although still in their infancy, face issues such as the time taken for the full 
development and function of a human tissue/organ etc, as time for organs to fully develop and 
function within animals takes a significantly less time in comparison to those in humans. [42].      
 
 
A)                                             B)                                            C) 
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ability to translate from the biomedical laboratory to the clinic is yet to be seen and realised 
practically. These issues arise from their inability to generate practical size tissues most 
relevant to humans alongside their associated processing times/number of steps to the 
involved costs for reconstructing a tissue/organ which could be transplanted. 
 
The author would like to make aware to the readers at this point that there are other methods 
currently being investigated for developing tissues/organs, within living animals. These 
methods although still in their infancy, face issues such as the time taken for the full 
development and function of a human tissue/organ in comparison to the time required for 
development and function of an animal tissue/organ. [42]     
 
 
2.2. Direct methods of scaffolding 
Direct methods of scaffolding unlike those in-direct methods can handle the cells mixed in 
with the biopolymer and a wide range of other materials such as proteins etc. The advantages 
of this over the other category is that these approaches require less steps to generate a 
structure and less bioreactor time for enabling cells to integrate with the materials and the 
structure. This also reduces other pit falls such as sterility issues and reduces costs. 
   
2.2.1. Lab on a chip approaches 
Lab on a chip also sometimes referred to as microfluidics, is an interesting micro volume 
liquid handling approach, which has been elucidated to have some attractive features. This 
technology comes alive when two pieces of polydimethylsiloxane (PDMS) have been fused 
together. Note that one piece of PDMS is flat on both sides while the other carries the 
imprinted flow route(s) as channels, having both inputs and outputs punched out through the 
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entire thickness of that piece of PDMS (figure 8). The base and materials which are generally 
used (above referred to as the PDMS piece having both sides flat) could be replaced with a 
glass microslide and there are many manifestations of this. Here liquids of various properties 
are introduced and mixed in precisely controlled volumes and studied for a wide range of 
applications. [43] This technology has been used for passing cellular suspensions for creating 
what is referred to as organ on a chip. [44] In addition to this advancement colleagues have also 
developed this technology to handle cells for cytometry studies and is referred to as 
fluorescent activated droplet sorting (FADS). [45] Although the technology has many 
advantages it is limited by its inability to scale up and handle high viscosity liquids to name a 
few, limiting the technology to the laboratory. Some disadvantages in FADS for e.g. is where 
the technology cannot handle cell suspensions of high viscosity which are regularly 
interrogated by its competing approach widely referred to as hydrodynamic focusing which 
takes place in the cytometer’s flow cell. [46] In the context of this review for building cellular 
architectures as referred to as organ on a chip the technology places cells in two-dimensions at 
best and stacks them in this configuration rather than in true three-dimensions. [47] We have 
noted that in some cases this technology is both inefficient and incapable of developing and 
generating tissues/organs, as the technology either demands the cells to be placed on the base 
of the chip prior to it being attached to its imprinted architecture thus squeezing and 
destroying cells out of the imprinted zone. This might not be such an issue with cells under 
investigation if they were fibroblasts (which are available in abundance), but this would not 
be the case with those rare cell populations. One way out of this obstacle is to keep the cells 
flowing through the chip continuously in the hope they will attach and cover the surface area 
desired but this raises the issue of time and the waste of complete media (media that 
comprises of all growth factors etc). Therefore, microfluidics limit the yield and have many 
obstacles to overcome before it could truly move from the laboratory to the clinic.  
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Figure 8. Two architectures amongst many famously investigated in lab chip based 
investigations. Panel A) depict a typical T-junction and B) demonstrates a flow focusing 
architecture. 
    
2.2.2. Laser guided cell printing 
Laser technology has been in the biological and medical fields for well over half a century. [48] 
This has come about by the technology widely referred to as flow cytometry which is a 
florescent activated cell sorting (FACS) technology. [46] Here lasers are used for interrogating 
the physio chemical nature of single cells, dynamically from a multi-cellular population. 
FACS is an unrivaled non-evasive single cell analysis technology which enables cells to be 
identified, sorted, and subsequently reintroduced into the human body, which is one 
A) 
B) 
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application amongst many others it has on offer. Laser guided cell writing or printing is where 
lasers are used as tweezers to pick cells up (or eject cells as a liquid jet etc) and place them 
where required (figure 9). [49] This is a very precise method of handling single cells for 
precise placement. The approach is uniquely capable of placing cells at different and precise 
proximities to each other and thus enables development biologists to closely study cellular 
interactions in either two- or three-dimensions. Unfortunately for the development of a three-
dimensional multi-cellular tissue, the technology is limited by its inability to handle multiple 
cell types simultaneously for generating a true three-dimensional tissue. The reader should 
note that laser tweezers generate high temperature at their tips and therefore the cells cannot 
be resident or held in such a harsh environment for long as this would compromise the cell’s 
viability.  
 
Figure 9. Illustrations showing A) a laser guided cell writing apparatus and B) a modified 
version which writes with the aid of a hollow fiber. 
 
2.2.3. Bio-electrospraying (BES) and cell electrospinning (CE) 
These techniques have evolved from both the basic technologies referred to as electrosprays 
and electrospinning. [26, 27] As mentioned previously (section 2.1.6), both these technologies 
work on the same principal. In summary both these approaches charge a flowing liquid within 
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Figure 9. laser writing or printing 
 
2.2.3. Bio-electrospraying (BES) and cell electrospinning (CE) 
These techniques have evolved from both the basic electrosprays and electrospinning. [26, 27] 
As mentioned previously (section 2.1.6), both these technologies work on the same principal. 
In summary both these approaches charge a flowing liquid within a needle which is held in an 
electric field brought about by a potential difference caused by a ground electrode or 
oppositely charged electrode placed on the opposed side of the charged needle. The electric 
field draws out the charged liquid towards the counter electrode and either forms a jet which 
undergoes break up and forms droplets or elongates into a continuously fiber. The former is 
electrosprays and the latter is electrospinning. In 2005/2006 Jayasinghe et al., [50] started 
exploring the ability to pass living cells through both these techniques and demonstrated their 
ability to do so without harming the cells from a molecular level upwards (figure 10). [51] The 
reader should be aware that processed living cells or organisms directly handled are not 
perturbed from a molecular level upwards, as the current is the effecting parameter in these 
studies and are generally in the nanoamperes, whilst the voltage is in the thousands of volts. 
[52] Hence the case in electroporation studies [52] and not in both taser guns and those studies 
carried out in electrosurgery/electrocuting. [53]  
Fiber 
Lens 
Laser 
Lens 
Laser 
Direction of substrate movement Direction of substrate 
Cells 
Cells 
A) B) 
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a needle which is held in an electric field brought about by a potential difference caused by a 
ground electrode or oppositely charged electrode placed on the opposed side of the charged 
needle. The electric field draws out the charged liquid towards the counter electrode and 
either forms a jet which undergoes break up and forms droplets or elongates into a continuous 
fiber. The former is electrosprays and the latter is electrospinning. In 2005/2006 Jayasinghe et 
al., [50] started exploring the ability to pass living cells through both these techniques and 
demonstrated their ability to do so without harming the cells from a molecular level upwards 
(figure 10). [51] The reader should be aware that processed living cells or organisms directly 
handled are not perturbed from a molecular level upwards, as the current is the effecting 
parameter in these studies, and are generally in the nanoamperes, whilst the voltage is in the 
thousands of volts. [52] In electroporation studies the opposite takes places, and therefore is 
found to damage cells. Those bio-electrospay and cell electrospinning operational conditions 
are also used in taser gun technology. [53] In a translational standpoint electric fields are used 
effectively and frequently in the clinic for surgery, through the technology referred to as 
electrosurgery/electrocuting. [53]  
 
 
A) 
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Figure 10. A) Characteristic plots demonstrating gene expression profiles of whole human 
blood of the needle control, NC and the bio-electrosprayed, BES sample. All genes were 
cross-compared with all other genes, hence giving 78 sets of data from 13 genes analysed. 
The red coloured bars represent BES samples and the blue bars represent the NC. The insert 
graph is the global average change in gene expression relative to the control with standard 
error bars and B) Gene expression is not altered on post-BES neonatal rat cardiac myocyte. 
MvA plots generated using bioconductor and gene array results compared between the culture 
control, CC, needle control, NC and bio-electrosprayed, BES. The vertical axis represents the 
intensity difference (M) and the horizontal axis the average intensity (A) plotted on a log 2 
scale. Ischaemic cardiac tissue is represented by the positive control group with differential 
expression. 
         
Since then the technologies have not only been used for handling single and multiple dense 
populations of cells (ranging from mouse and human immortalized, primary, sperm to stem 
B) 
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cells) but have also handle multiple cell suspensions including those whole fertilized embryos 
etc (figure 11). [54]  
 
 
 
Figure 11. Panels show the model organisms BES and CE, A) Drosophila melanogaster, B) 
Xenopus tropicalis, C) Danio rerio, D) Caenorhabditis elegans and E) Dictyostelium 
discoideum. All the organisms post-treated were observed over a given time course 
respectively, and seen to develop as expected in comparison to control samples. 
 
These continued efforts have seen generated tissues by way of either BES or CE being 
transplanted into mouse/rat to sheep and pig models. [55] These studies are the first of their 
kind for any such cell handling approach to be tested in animal models for assessing their 
efficacy and their true potential (figure 12). These platform technologies have also undergone 
development for modelling human tuberculosis [56] and a wide range of other human diseases 
which show the true applicability and flexibility of these platforms.  
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Figure 12. A) Bioluminescent imaging of transplanted macrophage bearing matricies. IC-21-
Luc macrophages (CC or BES) were mixed with matrices (Hydrogel, Soft, or Soft+) and 
subcutaneously injected into the dorsal flanks of C57Bl/6 mice (with Culture Control, CC on 
the left flank and bio-electrosprayed, BES on the right). Following intraperitoneal injection of 
d-luciferin, macrophage bioluminescence was detected using an IVIS Lumina II imaging 
system. Representative image from day 1 post-implantation, indicating the peak detectable 
radiance in identically sized regions of interest. The cell electrospun, CE results were very 
similar to the BES implants, B) Histological analysis of the macrophage bearing matrices 
implantation site. Four days post-implantation, skin was harvested from each dorsal flank, and 
processed for histology. The various matriciess (indicated by *) were discernible within the 
subcutis. Cells with the morphological appearance of macrophages were visible surrounding 
the matrices, with a scattering of cells within the matrix. Scale bar: 200 µm. 
 
 
2.2.4. Aerodynamically assisted bio-jetting (AABJ) and threading (AABT)   
This is jetting process which explores a pressure field through air flow, within a chamber with 
respect to the surrounding atmosphere, for drawing liquids of varied viscosities through an 
exit orifice (figure 13). [57] Much like in the case of both electrosprays and electrospinning the 
viscosity of the liquid determines the formation of either droplets or continuous threads 
(aerodynamically assisted jets/AAJ and threads/AAT respectively). [58] The process similar to 
both electrosprays and electrospinning have been explored for processing a wide range of 
materials and suspensions, which have been shown as a competing non-electric field driven 
process for handling a wide range of materials. [59] An interesting thought the reader should 
note is that these non-electric field driven processes are idea for handling those materials 
which are highly conducting which cannot be handled by either electrosprays or 
electrospinning as they would give rise to discharging or the damaging of those conducting 
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molecules. Both AAJ and AAT have been explored for directly handling a wide range of 
living cells and organisms with other materials and have been found to have no detrimental 
effects brought on the cells or organisms. [60] Since discovering the ability for both AAJ and 
AAT to handle living cells etc, the technologies have been explored for generating living 
constructs which have been transferred into small animals which have shown no rejection, 
and therefore shows their capacity to contribute to the development of tissues and/or organs. 
[54, 60] These platform technologies now are referred to as aerodynamically assisted bio-jets 
and bio-threads (AABJ/AABT respectively). These aerodynamically assisted processes have 
also undergone coupling with electric fields for applications in controlled deposition to the 
use of these modified systems for printing (controlled volumes of materials) and building 
architectures as those generated in 3D printing. [57, 63] There are manifestations (pressure 
assisted cell spinning and pressure driven cell spinning) of these processes which have also 
been investigated and shown to possess the ability to handle living cells and organisms. [61] 
AABJ at present is undergoing intense investigation as a sheathless flow cell technology for 
its entry into flow cytometry and FACS. [62]     
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Figure 13. Representative digital images of the A) single, B) coaxial and C) triaxial needle 
systems explored in the aerodynamically assisted jetting and threading devices. Panel D) 
shows the residues generated and collected with the triaxial needle configuration, E) cell 
encapsulated scaffold generated by way of a coaxial aerodynamically assisted bio-threading 
device to finally, F) microbubbles generated using a single AAJ device.   
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Figure 13 insert pics of the many structures that have been created with these techs. 
 
 
 
 
 
3. Applications  
3.1. Cell expansion and cryopreservation 
Cell expansion and preservation, for later use is common practice in regenerative biology and 
medicine. Classical approaches to cell expansion has been where cells have been isolated 
from given native tissue and expanded in sterile flasks maintained in an incubator within a 
A) B) C) 
D) E) F) 
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3. Possible translational applications  
3.1. Cell expansion and cryopreservation 
Cell expansion and preservation for later use is common practice in regenerative biology and 
medicine. Classical approaches to cell expansion has been where cells have been isolated 
from given native tissue and expanded in sterile flasks maintained in an incubator within a 
given complete media. This approach has allowed cell expansion in practical quantities but 
have also had the negative effect of their expansion being either slowed and/or not successful 
as the cells are expanding over a 2D space. Also, the process is not economical as the foot 
print of these flasks are relatively large and therefore demands large numbers of incubators 
etc. Some of these issues have been addressed through the multi-platform cell culture flask 
which has many platforms of which cells could expand on within the same flask. [63] Although 
this is a step in the right direction cells are yet expanding in the 2D! With the ability to form 
either encapsulated or entrapped cells within either beads or scaffolds such as those generated 
using either BES/CE and AABJ/AABT, the foot print of those architectures could be smaller 
and yet the cells would have access to those nutrients etc in true 3D. In our hands, we have 
explored both these techniques for this purpose with the expansion of primary human cell 
types and found that a much higher percentage of cells are recovered over the same time when 
compared with those expanded using conventional methods. This results as the cells are in 3D 
and hence have access to nutrients in 3D. Furthermore having control over the pore sizes of 
these cell-bearing beads and fibers nutrient/molecular gating could be enabled. Similar, cell 
bearing architectures have been frozen down to -800C and have been thawed and assessed for 
their percentage of recovery, viability and functionality in contrast to those classical 
approaches. These studies have demonstrated a greater yield of cells recovered from these 3D 
architectures generated by way of these techniques (BES/CE and AABJ/AABT) in 
comparison to those recovered from classical methods over the same time frame of freezing. 
This is a direct result of the processes allowing the controlled compartmentalization of cells 
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within a given layer (either as a multi compartmentalized bead or multicore fiber/scaffold) of 
liquid/polymer which would both control the cells experiencing the lowering of the 
temperature during the freezing process, to the cells gentling getting accustomed to the 
increasing of temperature, within these architectures allowing the cells to thaw during the cell 
recovery process. 
     
3.2. Reverse engineering natural scaffolds an alternative to decellularisation and 
recellularisation  
The author introduced and discussed earlier the method referred to as decellularisation and 
recellularisation. This technology although appearing to have some significance still demands 
a majority of its tissues and/or organs from the donor pool, which is oversubscribed, or from a 
regulated animal house for sourcing its tissues and organs. Once these tissues or organs are 
sourced, the cells are teased out of these tissues/organs, using bio-friendly chemical cocktails 
which have been shown to compromise the decellularised scaffold. Many other unknowns 
regarding the cell-free scaffold have yet to be answered, such as residual DNA which may 
cause negative effects on the repopulated cells and those other side effects which may arise 
due to the residual DNA etc. Cell electrospinning and aerodynamically assisted bio-threading 
have been shown to generate architectures which have been transplanted into animal models 
and have shown no negative effects. Thus, it is plausible to generate a three-dimensional 
human tissue which could be incubated for complete integration and maintained over a 
function of time. Such tissues could later be decellularised and recellularised with the 
recipient’s cells. Thus, avoiding the need to source tissues and organs from either the donor 
pool or an animal source, which would completely remove the need for life long 
immunosuppression to the patient. Additionally, the required number of steps for generating a 
recellularised functional 3D reconstruct would take much less time to those approaches 
followed by the conventional methods of decellularisation and recellularisation. This stems 
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from the fact that those architectures generated via either CE/AABT have the cells already 
integrated with the biopolymer and other biomolecules during the reconstruction stage.  
   
3.3. Development of functional three-dimensional model tissue  
Although there said to be many methods to developing three-dimensional fully functional 
tissues, these approaches have many steps which are laborious and require long time frames 
amongst other obstacles, which need to be overcome to generate a 3D tissue. These methods 
have many limitations and at best are in 2D and not in 3D. This is not the case for those 
reconstructs generated by way of BES/CE and AABJ/AABT, which have shown to hold cells 
in 3D to one another whilst maintaining their dynamic metabolisms and allowing cells to 
carry out all their expected cellular behavior. In fact, reconstructs generated by either of these 
processes (BES/CE and AABJ/AABT) have been explored to assess their ability to model 
human tuberculosis, showing great promise when compared to those approaches used to 
model the same disease in 2D or in animal models. These studies pave the way for these 
approaches to entire and promote the ability to carry out a wide range of biological studies for 
high through-put screening to the development of vaccines and drugs to their discovery, to 
finally carrying out humane research, which avoids sacrificing large numbers of animal 
models previously explored to carry out these very investigations.    
 
3.4. Tissue reconstruction for patching damaged and/or ageing tissues/organs to cell therapy 
The author previously stated that although there are many approaches to developing a tissue, 
the methods discussed in this review present those that are best placed to do so bearing in 
mind the time taken to generate a tissue with the least number of steps. There is a huge 
perception that 3D printing can develop a 3D fully functional tissue, which in this review has 
been shown to not be the case. This is due to its inability for those many manifestations of 3D 
printing to handle multi-cellular densely populated cell suspensions, with a biopolymer and 
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other materials such as proteins etc. In this instance BES/CE and AABJ/AABT overcome 
these limitations faced by its rival technologies as the needles used for accommodating the 
cellular suspensions etc are large in their bore diameter in comparison to any other direct cell 
handling approaches, yet are able to generate single cellular sized residues without the need 
for exploring prefabricated substrates. Additionally, the processing speed of these techniques 
are far greater than any rival technology and have been biologically, chemically, and 
physically fully assessed in comparison to control cells and whole organisms. Thus, 
establishing these approaches as the front running flexible platform biotechnologies in the 
endeavor for reconstructing a fully functional 3D tissue. Tissues reconstructed by way of 
these approaches (BES/CE and AABJ/AABT) have undergone intense in-vivo studies 
demonstrating the ability to develop tissues for transplantation. Such reconstructs can not only 
be explored for tissue and organ repair, rejuvenation and replacement but could also be used 
as localized cell therapy approaches for delivering a whole host of biological therapies 
(experimental and medical cells and/or genes).  
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4. Conclusion 
This critical review set out to introduce the many scaffolding approaches said to have the 
ability to significantly contribute to the field of regenerative biology and medicine. As there 
are many such technologies for handling living cells the author carefully chose which 
approaches to highlighted based on their perceived progress highlighted in the literature. That 
being said the author also clarified at the onset of this review that the rules for choosing the 
approaches highlighted in this review were solely based on the ability to build a true three-
dimensional tissue in practical dimensions, at low costs and with the least number of 
processing steps and time for reconstructing a living architecture. The author did so 
categorizing the many methods into two sets, namely which were established as the direct and 
in-direct methods of developing a tissue. The in-direct methods discussed lithography 
approaches, chemical methods, 3D printing, cell sheeting, force spinning, 
electrosprays/electrospinning and finally decellularization and recellularization. All these 
methods were discussed in detailed but shared one common obstacle which were that they had 
many laborious processing stages involved in order to see the generation of a fully 
cellularised scaffold.  Although these approaches are not capable of entering the clinic for 
mass utility as a result of their practicality, the techniques were shown to have some utility in 
small-scale in niches areas. An important feature the in-direct scaffolding methods lacked was 
their inability to handle the cells with the biopolymer and other biomolecules such as proteins 
etc for the direct formation of a living tissue. Instead they required many steps in order to 
reconstruct a tissue which at the end had too many steps which introduces many other 
complications such as sterility and their inability to place cells in true three-dimensions. In 
contrasts, direct methods of scaffolding were able to handle all the constituents of a living 
tissue directly which could be deposited for the reconstruction of a living architecture. 
Nonetheless the many approaches discussed in this category had other limitations where the 
cell densities needed to be controlled together with, in some cases their inability like in the 
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category of in-direct methods for not possessing the ability for placing cells in true three-
dimensions. In this category, we discussed lab on chip, laser guided cell writing, bio-
electrosprays/cell electrospinning, and finally aerodynamically assisted bio-jetting and 
threading. 
 
The author argued, the most favorable processes were bio-electrosprays/cell electrospinning, 
and aerodynamically assisted bio-jetting and threading. These were due to their ability to 
handle all the required materials with living cells to form large quantities of cell bearing beads 
or scaffold without perturbing the cells from a molecular level upwards. Interestingly, in the 
literature processes such as lab on chip, laser guided cell writing and 3D printing of cells etc 
have been discussed but have limited details reported on the cell viability using well 
established biological interrogating approaches such as flow cytometry to other molecular 
level analysis (karyotyping, gene micro arrays, RT-PCR or even RNA–Seq). This leaves the 
author with much skepticism in regards to those results discussing cellular viability and well-
being. Additionally, apart from bio-electrosprays/cell electrospinning, and aerodynamically 
assisted bio-jetting and threading no other approach had undergone rigorous in-vivo testing, 
hence this left the author in a difficult position as it make comparison difficult.  
 
At present bio-electrosprays and cell electrospinning are undergoing their checks through 
preclinical trials and it is hoped that these studies will bring out further their applicability to 
the real world and see them enter the clinic in the not so distant future. In parallel, these 
approaches are being regularly used in the biomedical laboratories for developing biological 
models, for understanding basic biology to the testing of a wide range of compounds and 
molecules to the development of these approaches for many other applications. It is hoped 
that these approaches together with their non-electrified driven technologies will enter phase I 
clinical studies soon. 
  
37 
 
Finally, this critical review set out to elucidate to the readers the advantages and 
disadvantages of those many approaches said to have promise in the regenerative biology and 
medicinal areas of research and development. The author hopes these thoughts discussed in 
this review provokes the readers to think outside the envelope and possibly see the arguments 
raised in this review and their real applicability for translation to either the biomedical 
laboratory and/or the clinic.  
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Scaffolds are pivotal in the development of synthetic tissues for a wide range of 
applications in the biomedical and clinical sciences. Recent developments in the field of 
bioscaffolds are reviewed and discussed. 
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